TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33050924

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine 200 mg, 2 tablets BID on day 0, 2 tablets QD from day 1 to 9
Number of subjects: 1057

Group type: EXPERIMENTAL
Intervention: Imatinib 400 mg, 1 tablet QD from day 0 to 9
Number of subjects: 1057

Group type: EXPERIMENTAL
Intervention: Favipiravir 200 mg, 12 tablets BID on day 0, 6 tablets BID from day 1 to 9
Number of subjects: 1057

Group type: EXPERIMENTAL
Intervention: Telmisartan 20 mg, 1 tablet QD from day 0 to 9
Number of subjects: 1057

Group type: COMPARATOR
Intervention: Complex of vitamins and trace elements (AZINC Forme et Vitalité®), 1 capsule BID for 10 days
Number of subjects: 1057
Study: 32042407

Group type: EXPERIMENTAL
Intervention: Cod protein hydrolysate (CPH) 10 mg/kg BW
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Cod protein hydrolysate (CPH) 40 mg/kg BW
Number of subjects: 31
Study: 32838661

Group type: EXPERIMENTAL
Intervention: Trimetazidine
Number of subjects: 760

Group type: COMPARATOR
Intervention: Control (hydration therapy)
Number of subjects: 760
Study: 35236256

Group type: EXPERIMENTAL
Intervention: Internal Heel Wedge (IHW)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: External Heel Wedge (EHW)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (no podalic stimulation)
Number of subjects: 42
Study: 34036689

Group type: EXPERIMENTAL
Intervention: Group-cognitive-behavioral therapy (CBT)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 70
Study: 35390490

Group type: EXPERIMENTAL
Intervention: Vitality Acupunch (VA) exercise, 3 times a week, 40 min each session for 24 weeks
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group (regular activities of daily living)
Number of subjects: 81
Study: 34061380

Group type: EXPERIMENTAL
Intervention: U-NetAC
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: AutoencoderAC
Number of subjects: 236

Group type: COMPARATOR
Intervention: ChangAC
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: CTAC
Number of subjects: 236
Study: 36162986

Group type: EXPERIMENTAL
Intervention: Autonomy-supportive communication style
Number of subjects: 1918

Group type: COMPARATOR
Intervention: Controlling communication style
Number of subjects: 1918

Group type: COMPARATOR
Intervention: External motivators (monetary voucher or corona pass)
Number of subjects: 1918
Study: 33692297

Group type: EXPERIMENTAL
Intervention: Modafinil
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 32897035

Group type: EXPERIMENTAL
Intervention: Continuous molgramostim (300 μg once daily by inhalation)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 138
Study: 35634513

Group type: EXPERIMENTAL
Intervention: 10‐7 M melatonin added to the culture medium; n=48
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 10‐7 M melatonin added to the culture medium; n=71
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group; n=72
Number of subjects: 42
Study: 34786350

Group type: EXPERIMENTAL
Intervention: MoodGYM plus Check Your Drinking (M + CYD)
Number of subjects: 986

Group type: COMPARATOR
Intervention: MoodGYM (M-only)
Number of subjects: 986
Study: 32617805

Group type: EXPERIMENTAL
Intervention: Scanning Slit Topography (SST)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Infrared Pachymetry (IRP)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Ultrasound Pachymetry (USP)
Number of subjects: 95
Study: 34469338

Group type: EXPERIMENTAL
Intervention: 6-mm cylindrical light guide
Number of subjects: 85

Group type: COMPARATOR
Intervention: 8 × 15-mm cylindrical light guide
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Both groups (6-mm and 8 × 15-mm light guides)
Number of subjects: 85
Study: 34085873

Group type: EXPERIMENTAL
Intervention: Assessment and feedback combined with vaccine communication training and behavioral nudges (vaccine commitment posters)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Assessment and feedback
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Both intervention groups (assessment and feedback with communication training and behavioral nudges, and assessment and feedback alone)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Parents of HPV vaccine-hesitant children
Number of subjects: 215
Study: 33333513

Group type: EXPERIMENTAL
Intervention: Mansoura Fiberoptic Endoscopic Evaluation of Swallowing Residue Rating Scale (MFRRS)
Number of subjects: 30
Study: 35237860

Group type: EXPERIMENTAL
Intervention: Drug-coated balloon angioplasty (DCBA)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Conventional percutaneous transluminal angioplasty (PTA)
Number of subjects: 138
Study: 32529903

Group type: EXPERIMENTAL
Intervention: Longitudinal orientation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Transverse orientation
Number of subjects: 100
Study: 35295236

Group type: EXPERIMENTAL
Intervention: Lesogaberan 120 mg modified release twice daily
Number of subjects: 22

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 22
Study: 32339978

Group type: EXPERIMENTAL
Intervention: Palliative chemotherapy
Number of subjects: 720
Study: 34209581

Group type: EXPERIMENTAL
Intervention: Stim
Number of subjects: 89

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 89
Study: 35928056

Group type: EXPERIMENTAL
Intervention: Mifepristone (200 mg) on days one and two, followed by misoprostol (200 or 400 μg, vaginally, six-hourly, up to three doses in 12 h)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Mifepristone (one dose on day one) followed by misoprostol on day three (historical control)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Mifepristone (200 mg) on days one and two, followed by misoprostol
Number of subjects: 200
Study: 35797219

Group type: EXPERIMENTAL
Intervention: nab-paclitaxel 125 mg/m2 + gemcitabine
Number of subjects: 336

Group type: COMPARATOR
Intervention: carboplatin
Number of subjects: 336

Group type: COMPARATOR
Intervention: Additional anthracycline-containing chemotherapy
Number of subjects: 336
Study: 34039277

Group type: EXPERIMENTAL
Intervention: Mobile application for monitoring patients under home oxygen therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional follow‐up methods (periodic visits of a respiratory therapist)
Number of subjects: 0
Study: 35938620

Group type: EXPERIMENTAL
Intervention: Listening to music of their own choice during the procedure
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group (no music)
Number of subjects: 93
Study: 35217351

Group type: EXPERIMENTAL
Intervention: 2 mA cathodal high-definition tDCS targeting the seizure-onset zone for 30 minutes for 2 weeks (10 sessions total).
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cathodal high-definition tDCS (treatment group)
Number of subjects: 20
Study: 32912305

Group type: EXPERIMENTAL
Intervention: CareHand app
Number of subjects: 58

Group type: COMPARATOR
Intervention: Conventional treatment (control)
Number of subjects: 58
Study: 35215057

Group type: EXPERIMENTAL
Intervention: Probiotic lozenges (two per day for 90 days) with regular oral hygiene
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo lozenges (two per day for 90 days) with regular oral hygiene
Number of subjects: 116
Study: 34533249

Group type: EXPERIMENTAL
Intervention: Metformin and ALES (artichoke leaf extract)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin E and ALES (artichoke leaf extract)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metformin and Vitamin E
Number of subjects: 0
Study: 33375899

Group type: EXPERIMENTAL
Intervention: Compassion-Focused Therapy (CFT) - 8 sessions
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group - no therapy
Number of subjects: 42
Study: 33091587

Group type: EXPERIMENTAL
Intervention: Intervention group receiving EHR-based best practice alert and psychiatrist review of prescriptions.
Number of subjects: 800

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 800
Study: 35033158

Group type: EXPERIMENTAL
Intervention: Average blood glucose level
Number of subjects: 182
Study: 32239365

Group type: EXPERIMENTAL
Intervention: Recovery-oriented cognitive behavioural workshop
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Online booster session
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Duration of illness and older age
Number of subjects: 0
Study: 36272846

Group type: EXPERIMENTAL
Intervention: Reiki
Number of subjects: 159

Group type: COMPARATOR
Intervention: Sham Reiki
Number of subjects: 159

Group type: COMPARATOR
Intervention: Control
Number of subjects: 159
Study: 33460300

Group type: EXPERIMENTAL
Intervention: Audiovisual dissection manual (n = 96)
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Improved written manual (n = 94)
Number of subjects: 279

Group type: COMPARATOR
Intervention: Standard dissection manual (Control group, n = 89)
Number of subjects: 279
Study: 34766664

Group type: EXPERIMENTAL
Intervention: Patient-centred clinical prediction tool and e-health platform
Number of subjects: 14

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 14
Study: 34762057

Group type: EXPERIMENTAL
Intervention: Mobile diary app
Number of subjects: 78

Group type: COMPARATOR
Intervention: Paper-based diary cards
Number of subjects: 78
Study: 33149136

Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis at the start of anti‐myeloma treatment
Number of subjects: 838

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 838

Group type: EXPERIMENTAL
Intervention: Myeloma patients
Number of subjects: 838
Study: 616553345

Group type: EXPERIMENTAL
Intervention: 5-Fluorouracil 0.5%/Salicylic Acid 10%
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study: 34529869

Group type: EXPERIMENTAL
Intervention: Combination therapy of transobturator tape sling (TOT) and low-dose Abobotulinumtoxin-A injection (300 U injected in 20–30 sites)
Number of subjects: 60

Group type: COMPARATOR
Intervention: TOT surgery alone
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combination therapy (Part 2)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 60
Study: 32396266

Group type: EXPERIMENTAL
Intervention: CYP4V2 H331P variant
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: CYP4V2 G410C variant
Number of subjects: 60

Group type: COMPARATOR
Intervention: Wild-type CYP4V2
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Other four CYP4V2 amino variants
Number of subjects: 60
Study: 33632930

Group type: EXPERIMENTAL
Intervention: Doxorubicin at 75 mg/m2 for eight cycles
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: Doxorubicin at 75 mg/m2 for eight cycles with dexrazoxane coadministration
Number of subjects: 504
Study: 35882292

Group type: EXPERIMENTAL
Intervention: CBD supplement (Hemp Extract, 150 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (supplement pellets without CBD)
Number of subjects: 20
Study: 33408145

Group type: EXPERIMENTAL
Intervention: Tenecteplase (TNK) 0.25 mg/kg or 0.40 mg/kg
Number of subjects: 110

Group type: COMPARATOR
Intervention: Alteplase 0.9 mg/kg
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Tenecteplase (TNK)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Alteplase
Number of subjects: 110
Study: 32664094

Group type: EXPERIMENTAL
Intervention: Intravenous phenylephrine infusion (0.5 μg/kg/min) for 5 minutes before BCP
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Intravenous phenylephrine infusion (1.0 μg/kg/min) for 5 minutes before BCP
Number of subjects: 66

Group type: COMPARATOR
Intervention: Intravenous normal saline (control group)
Number of subjects: 66
Study: 34261364

Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Methylnaltrexone (0.3 mg/kg IV)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 33350782

Group type: EXPERIMENTAL
Intervention: Tong-Xie-An-Chang Decoction (TXACD)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Pinaverium bromide tablets placebo
Number of subjects: 72

Group type: COMPARATOR
Intervention: Pinaverium bromide tablets
Number of subjects: 72
Study: 36174595

Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine (3-day course of twice-daily dosing followed by weekly dosing for 4 weeks)
Number of subjects: 1480

Group type: COMPARATOR
Intervention: Multivitamin (no antimalarial activity)
Number of subjects: 1480

Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine
Number of subjects: 1480

Group type: COMPARATOR
Intervention: Multivitamin
Number of subjects: 1480
Study: 36112940

Group type: EXPERIMENTAL
Intervention: SuperSpeed Golf™ weighted-club warm-up
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control warm-up
Number of subjects: 12
Study: 32316994

Group type: EXPERIMENTAL
Intervention: Different methods of applying KDIGO criteria for AKI
Number of subjects: 1010

Group type: EXPERIMENTAL
Intervention: Different methods of estimating missing baseline serum creatinine (sCr)
Number of subjects: 1010

Group type: EXPERIMENTAL
Intervention: Different methods of handling urine output (UO)
Number of subjects: 1010

Group type: EXPERIMENTAL
Intervention: All 30 variations of KDIGO criteria
Number of subjects: 1010
Study: 35509395

Group type: EXPERIMENTAL
Intervention: High-flow nasal oxygen (HFNO) at 40 L min−1
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard low-flow nasal cannula (NC group)
Number of subjects: 40
Study: 32838710

Group type: EXPERIMENTAL
Intervention: Capsinoids (CSN) 12 mg, single dosage
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo capsules with a high‐carbohydrate meal (2 g carb/kg bodyweight)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Capsinoids (CSN)
Number of subjects: 9
Study: 35968688

Group type: EXPERIMENTAL
Intervention: Face-to-face learning
Number of subjects: 82

Group type: COMPARATOR
Intervention: Online learning
Number of subjects: 82
Study: 34599622

Group type: EXPERIMENTAL
Intervention: Low AGE diet for 1 month
Number of subjects: 20

Group type: COMPARATOR
Intervention: Usual diet
Number of subjects: 20
Study: 35836948

Group type: EXPERIMENTAL
Intervention: 16-session acupuncture at true acupoints for 4 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Non-penetrating sham acupuncture at non-acupoints for 4 weeks
Number of subjects: 80
Study: 33256506

Group type: EXPERIMENTAL
Intervention: Breviscapine (BRE) 120 mg daily (40 mg, three times a day) for 14 days
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo for 14 days
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both BRE and placebo groups
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: MDR1 C3435T gene polymorphisms (CC, CT, TT genotypes)
Number of subjects: 18
Study: 34329898

Group type: EXPERIMENTAL
Intervention: Adenotonsillectomy
Number of subjects: 398

Group type: COMPARATOR
Intervention: Watchful waiting
Number of subjects: 398
Study: 32335402

Group type: EXPERIMENTAL
Intervention: Low testosterone (T) group
Number of subjects: 2118

Group type: COMPARATOR
Intervention: Normal testosterone (T) group
Number of subjects: 2118
Study: 35241032

Group type: EXPERIMENTAL
Intervention: Early pelvic circumferential compression device (pelvic binder)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (conventional stepwise approach)
Number of subjects: 30
Study: 34581297

Group type: EXPERIMENTAL
Intervention: TearCare (TC)
Number of subjects: 135

Group type: COMPARATOR
Intervention: LipiFlow (LF)
Number of subjects: 135
Study: 34661682

Group type: EXPERIMENTAL
Intervention: Erector spinae plane (ESP) block with 20ml of 0.25% levobupivacaine plus dexamethasone 2mg per side
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard multimodal analgesia with tramadol 100mg at the end of the procedure
Number of subjects: 60
Study: 34053466

Group type: EXPERIMENTAL
Intervention: Preventive integrated vector management (IVM) strategy including targeted outdoor residual spraying with K-Othrine Polyzone, deployment of mosquito traps as auto-dissemination devices, and community engagement activities.
Number of subjects: 300

Group type: COMPARATOR
Intervention: Routine vector control activities only.
Number of subjects: 300
Study: 32759361

Group type: EXPERIMENTAL
Intervention: RT-CGM/GTS
Number of subjects: 72

Group type: COMPARATOR
Intervention: POC
Number of subjects: 72
Study: 36453681

Group type: EXPERIMENTAL
Intervention: Tong Guan Li Qiao needling method combined with swallowing training
Number of subjects: 116

Group type: COMPARATOR
Intervention: Swallowing training (control group)
Number of subjects: 116
Study: 32691513

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 5 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35862407

Group type: EXPERIMENTAL
Intervention: Home based couple education and counseling
Number of subjects: 288

Group type: COMPARATOR
Intervention: Standard of care (control)
Number of subjects: 288
Study: 34621181

Group type: EXPERIMENTAL
Intervention: HIIT+RT
Number of subjects: 26

Group type: COMPARATOR
Intervention: RT+HIIT
Number of subjects: 26
Study: 35251558

Group type: EXPERIMENTAL
Intervention: Rehabilitation intervention-centered targeted nursing model (group A)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine nursing combined with rehabilitation intervention (group B)
Number of subjects: 120
Study: 34397234

Group type: EXPERIMENTAL
Intervention: Thue-Morse quasiperiodic driving
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Random multipolar driving
Number of subjects: 0
Study: 32345372

Group type: EXPERIMENTAL
Intervention: Azathioprine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Dapsone
Number of subjects: 90
Study: 32907384

Group type: EXPERIMENTAL
Intervention: Mobile health smartphone application-based programme
Number of subjects: 78

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 78
Study: 32268896

Group type: EXPERIMENTAL
Intervention: Self-management intervention (SMI)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Education-based intervention (EDU)
Number of subjects: 113
Study: 33387342

Group type: EXPERIMENTAL
Intervention: Preoperative isometric exercise (handgrip device and elastic band for 8 weeks)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 138
Study: 36319585

Group type: EXPERIMENTAL
Intervention: Olive leaf extract 250 mg every 12 hours for five days
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Olive leaf extract 500 mg every 12 hours for five days
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo every 12 hours for five days
Number of subjects: 150
Study: 33888191

Group type: EXPERIMENTAL
Intervention: Moderate levels of daily physical activity
Number of subjects: 9269

Group type: EXPERIMENTAL
Intervention: High levels of daily physical activity
Number of subjects: 9269
Study: 32959370

Group type: EXPERIMENTAL
Intervention: Create Healthy Futures program (self‐paced, 6‐lesson, web‐based intervention)
Number of subjects: 111
Study: 36448278

Group type: EXPERIMENTAL
Intervention: Collis Curve toothbrush
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Superfine nano toothbrush
Number of subjects: 16

Group type: COMPARATOR
Intervention: Conventional toothbrush (used for 4 weeks before special needs toothbrushes)
Number of subjects: 16
Study: 33798493

Group type: EXPERIMENTAL
Intervention: ASC plus FOLFOX
Number of subjects: 162

Group type: COMPARATOR
Intervention: ASC alone
Number of subjects: 162
Study: 34600945

Group type: EXPERIMENTAL
Intervention: 28 days meat-free pledge
Number of subjects: 325

Group type: COMPARATOR
Intervention: Control group (not pledging)
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: All participants
Number of subjects: 325
Study: 33534773

Group type: EXPERIMENTAL
Intervention: Latrines (case-houses)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Flushing toilets (control-houses)
Number of subjects: 48
Study: 36216656

Group type: EXPERIMENTAL
Intervention: Instructor-led lesson
Number of subjects: 104

Group type: COMPARATOR
Intervention: IVR lesson
Number of subjects: 104
Study: 34399702

Group type: EXPERIMENTAL
Intervention: Hip arthroscopy
Number of subjects: 99

Group type: COMPARATOR
Intervention: Physiotherapist-led management (Personalised Hip Therapy - PHT)
Number of subjects: 99
Study: 32000729

Group type: EXPERIMENTAL
Intervention: Stepping Stones Triple P (SSTP) parenting therapy (nine weeks, six group sessions and three individualised sessions) in addition to Treatment as Usual
Number of subjects: 258

Group type: COMPARATOR
Intervention: Treatment as Usual only (other available services in each location)
Number of subjects: 258
Study: 33359814

Group type: EXPERIMENTAL
Intervention: Proficiency-Based Progression (PBP) curriculum for arthroscopic Bankart repair (ABR)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Proficiency-Based Progression (PBP) curriculum for arthroscopic rotator cuff repair (ARCR)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Precourse baseline performance
Number of subjects: 18
Study: 33248070

Group type: EXPERIMENTAL
Intervention: EGCM (computer-aided diagnostic model)
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: EGCM
Number of subjects: 295
Study: 35812678

Group type: EXPERIMENTAL
Intervention: Psychosocial intervention (administered in eight sessions biweekly over 4 weeks)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 211
Study: 32711058

Group type: EXPERIMENTAL
Intervention: Bacterial co-infection (estimated on presentation)
Number of subjects: 3338

Group type: EXPERIMENTAL
Intervention: Secondary bacterial infection
Number of subjects: 3338

Group type: EXPERIMENTAL
Intervention: Overall bacterial infection
Number of subjects: 3338

Group type: EXPERIMENTAL
Intervention: Bacterial infection in critically ill patients
Number of subjects: 3338

Group type: EXPERIMENTAL
Intervention: Patients receiving antibiotics
Number of subjects: 3338
Study: 35738969

Group type: EXPERIMENTAL
Intervention: BCG intradermal vaccine
Number of subjects: 299

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 299
Study: 32997095

Group type: EXPERIMENTAL
Intervention: Self-expanding TAVR (iliofemoral access)
Number of subjects: 713

Group type: COMPARATOR
Intervention: SAVR
Number of subjects: 713

Group type: EXPERIMENTAL
Intervention: Self-expanding TAVR (noniliofemoral access)
Number of subjects: 713

Group type: COMPARATOR
Intervention: SAVR (noniliofemoral access)
Number of subjects: 713
Study: 33733257

Group type: EXPERIMENTAL
Intervention: Airway Ex mobile application (30 minutes of self-directed learning)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no use of mobile application)
Number of subjects: 45